Science Corporation implants its vision-restoring chip in its first Stargardt disease patient

Science Corporation has successfully implanted its PRIMA vision-restoration device into a patient suffering from Stargardt disease, a form of macular degeneration. Developed by former Neuralink co-founder Max Hodak, the implant aims to restore sight by using a sub-retinal chip to transmit visual data. This milestone represents a practical step toward broader brain-computer interface applications, signaling potential progress in treating degenerative eye conditions through neural technology.